CINCINNATI, April 12 /PRNewswire-FirstCall/ -- Kendle , a leading, global full-service clinical research organization, today announced several of its executives will speak on key industry issues at the 19th Annual Partnerships in Clinical Trials Conference being held April 12-14, 2010, in Orlando, Florida. Kendle experts will address topics including maximizing the value of strategic partnerships with CROs; the future of sponsor/clinical service provider relationships; and educating outsourcing managers in biomarkers, imaging and other technologies.
Kendle speakers as well as additional senior clinical development experts will be available at booth 338 for on-site meetings and to discuss the Company’s approach to successful partnerships focused on bringing greater innovation and value to the development process.
Kendle International Inc. is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world’s biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world’s largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers’ clinical development challenges.
CONTACT: Michael Lawson, Investors, +1-513-763-1992; or Lori Dorer, Media,
+1-513-345-1685
Web site: http://www.kendle.com/
